Doctor David Fortin, a researcher on the Fleurimont Health campus of the CIUSSS de l’Estrie – CHUS, announced a new method and research study on Tuesday aimed at improving the treatment of glioblastoma, a rare and very aggressive form of brain cancer. The new approach being championed by Fortin and his team is a combination of radiation therapy and chemotherapy, but catered to the individual based on specific and focused testing of tumor tissue in the moment it has been removed from the body. See full story in the Wednesday, October 10 edition of The Record.
Sherbrooke doctor taking new steps in the field of brain cancer
By Gordon Lambie
